Fanconi Anemia Complementation Group G Protein
"Fanconi Anemia Complementation Group G Protein" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A Fanconi anemia complementation group protein that undergoes PHOSPHORYLATION by CDC2 PROTEIN KINASE during MITOSIS. It forms a complex with other FANCONI ANEMIA PROTEINS and helps protect CELLS from DNA DAMAGE by genotoxic agents.
| Descriptor ID |
D052241
|
| MeSH Number(s) |
D12.776.313.906 D12.776.744.488
|
| Concept/Terms |
Fanconi Anemia Complementation Group G Protein- Fanconi Anemia Complementation Group G Protein
- XRCC9 Protein
- Fanconi Anemia Group G Protein
- X-Ray Repair Complementing Defective Repair In Chinese Hamster Cells 9 Protein
- X Ray Repair Complementing Defective Repair In Chinese Hamster Cells 9 Protein
- FANCG Protein
- Fanconi Anemia Group G Complementing Protein
|
Below are MeSH descriptors whose meaning is more general than "Fanconi Anemia Complementation Group G Protein".
Below are MeSH descriptors whose meaning is more specific than "Fanconi Anemia Complementation Group G Protein".
This graph shows the total number of publications written about "Fanconi Anemia Complementation Group G Protein" by people in this website by year, and whether "Fanconi Anemia Complementation Group G Protein" was a major or minor topic of these publications.
Below are the most recent publications written about "Fanconi Anemia Complementation Group G Protein" by people in Profiles.
-
Map of synthetic rescue interactions for the Fanconi anemia DNA repair pathway identifies USP48. Nat Commun. 2018 06 11; 9(1):2280.
-
Massively parallel sequencing, aCGH, and RNA-Seq technologies provide a comprehensive molecular diagnosis of Fanconi anemia. Blood. 2013 May 30; 121(22):e138-48.
-
Genomic instability in mice is greater in Fanconi anemia caused by deficiency of Fancd2 than Fancg. Cancer Res. 2010 Dec 01; 70(23):9703-10.
-
In vivo therapeutic responses contingent on Fanconi anemia/BRCA2 status of the tumor. Clin Cancer Res. 2005 Oct 15; 11(20):7508-15.
-
Direct interaction of the Fanconi anaemia protein FANCG with BRCA2/FANCD1. Hum Mol Genet. 2003 Oct 01; 12(19):2503-10.